US Patent 7355018 Modified IGF1 polypeptides with increased stability and potency
Patent 7355018 was granted and assigned to Regeneron Pharmaceuticals, Inc. on April, 2008 by the United States Patent and Trademark Office.
Is a
Date Filed
September 30, 2004
Date of Patent
April 8, 2008
Patent Application Number
10954468
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7355018 Modified IGF1 polypeptides with increased stability and potency
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.